Home > Category > Chiral Reagent > (5S)-5-[Diphenyl[(trimethylsilyl)oxy]methyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

(5S)-5-[Diphenyl[(trimethylsilyl)oxy]methyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

Daicel≥98%,99%e.e.

Catalog No：200545-100MG CAS No.：1126669-25-7 MDLNo： Brand:Daicel purity：≥98%,99%e.e. 特性： Purpose:

Share

Size	Availability	Price(USD)
100MG	请咨询	$1450.00

Chemical safety data sheet(MSDS)

Download MSDS

Inquiry

Product Overview
Related documents
Related literature

Product Overview

Product Name	(5S)-5-[Diphenyl[(trimethylsilyl)oxy]methyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate
CAS	1126669-25-7
Formula	C₃₀H₃₆N₃OSi·BF₄

Related literature

Sorry, there is no relevant literature

Related

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

(4S,4'S)-2,2'-(1-Phenylpropane-2,2-diyl)bis(4,5,5-triphenyl-4,5-dihydrooxazole)

2409652-68-0 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bS)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1639447-03-2 ≥95%,-

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

(11bR)-4-Hydroxy-2,6-bis(5'-phenyl[1,1':3',1''-terphenyl]-2'-yl)-4-dinaphtho[2,1-d:1',2'-f][1,3,2]dioxaphosphepinoxide

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1S)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

1,1'-[(1R)-2,2',3,3'-Tetrahydro-3,3,3',3',5,5'-hexamethyl-1,1'-spirobi[1H-indene]-7,7'-diyl]bis(diisopropylphosphane)

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

(S)-2,2'-Bis(diisopropylphosphanyl)-1,1'-binaphthalene

History

(5S)-5-[Diphenyl[(trimethylsilyl)oxy]methyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

(5S)-5-[Diphenyl[(trimethylsilyl)oxy]methyl]-6,7-dihydro-2-(2,4,6-trimethylphenyl)-5H-pyrrolo[2,1-c]-1,2,4-triazolium Tetrafluoroborate

1126669-25-7 ≥98%,99%e.e.

Pralidoxime chloride (2-PAM chloride)

Pralidoxime chloride (2-PAM chloride)

1-(Anilinocarbonyl)proline

1-(Anilinocarbonyl)proline

CPTH6 (hydrobromide)

CPTH6 (hydrobromide)

Tabersonine

Tofacitinib (CP-690550,Tasocitinib)

Tofacitinib (CP-690550,Tasocitinib)

SZ1676

AZD3229 Tosylate

AZD3229 Tosylate

AGN 205327

IM156